Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction
Abstract Background Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, myocardial fibrosis, and adverse clinical outcomes....
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2024-11-01
|
| סדרה: | BMC Cardiovascular Disorders |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1186/s12872-024-04364-2 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
